Search research articles
Contact Us
Filters
Showing results (1-10 of 154) with videos related to
Page
of 16
Sort By:
Peptides
|
May 25, 2005
The role of atrial natriuretic peptide in the immune system
Angelika M Vollmar
Cancer Letters
|
August 3, 2010
Targeting apoptosis pathways by natural compounds in cancer: marine compounds as lead structures and chemical tools for cancer therapy
Karin von Schwarzenberg, Angelika M Vollmar
Pharmazie in Unserer Zeit
|
July 27, 2005
[The history and status of transplantation medicine]
Angelika M Vollmar, Alexander L Gerbes
Endocrinology
|
April 12, 2008
Dexamethasone-induced expression of endothelial mitogen-activated protein kinase phosphatase-1 involves activation of the transcription factors activator protein-1 and 3',5'-cyclic adenosine 5'-monophosphate response element-binding protein and the generation of reactive oxygen species
Robert Fürst, Stefan Zahler, Angelika M Vollmar
Pharmaceuticals (Basel, Switzerland)
|
July 10, 2020
Cancer Patients Have a Higher Risk Regarding COVID-19 - and Vice Versa?
Franz Geisslinger, Angelika M Vollmar, Karin Bartel
International Journal of Molecular Sciences
|
April 17, 2025
Endothelial Sprout Formation Is Regulated by Substrate Stiffness and Notch Signaling
Maibritt Kretschmer, Angelika M Vollmar, Stefan Zahler
Pharmazie in Unserer Zeit
|
December 18, 2007
[The immunologic basis of vaccination. Hightech training for the immune system]
Ilse Zündorf, Angelika M Vollmar, Theo Dingermann
Current Medicinal Chemistry. Cardiovascular and Hematological Agents
|
January 11, 2005
Vasoprotective actions of the atrial natriuretic peptide
Alexandra K Kiemer, Robert Fürst, Angelika M Vollmar
Immunology and Cell Biology
|
October 31, 2002
Inhibition of LPS-induced nitric oxide and TNF-alpha production by alpha-lipoic acid in rat Kupffer cells and in RAW 264.7 murine macrophages
Alexandra K Kiemer, Christian Müller, Angelika M Vollmar
Angiogenesis
|
August 14, 2010
Anti-angiogenic potential of small molecular inhibitors of cyclin dependent kinases in vitro
Stefan Zahler, Johanna Liebl, Robert Fürst, et al.
Page
of 16
Search research articles
Search
Showing results (1-10 of 154) with videos related to
Sort By:
Page
of 16
Peptides
|
May 25, 2005
The role of atrial natriuretic peptide in the immune system
Angelika M Vollmar
Cancer Letters
|
August 3, 2010
Targeting apoptosis pathways by natural compounds in cancer: marine compounds as lead structures and chemical tools for cancer therapy
Karin von Schwarzenberg, Angelika M Vollmar
Pharmazie in Unserer Zeit
|
July 27, 2005
[The history and status of transplantation medicine]
Angelika M Vollmar, Alexander L Gerbes
Endocrinology
|
April 12, 2008
Dexamethasone-induced expression of endothelial mitogen-activated protein kinase phosphatase-1 involves activation of the transcription factors activator protein-1 and 3',5'-cyclic adenosine 5'-monophosphate response element-binding protein and the generation of reactive oxygen species
Robert Fürst, Stefan Zahler, Angelika M Vollmar
Pharmaceuticals (Basel, Switzerland)
|
July 10, 2020
Cancer Patients Have a Higher Risk Regarding COVID-19 - and Vice Versa?
Franz Geisslinger, Angelika M Vollmar, Karin Bartel
International Journal of Molecular Sciences
|
April 17, 2025
Endothelial Sprout Formation Is Regulated by Substrate Stiffness and Notch Signaling
Maibritt Kretschmer, Angelika M Vollmar, Stefan Zahler
Pharmazie in Unserer Zeit
|
December 18, 2007
[The immunologic basis of vaccination. Hightech training for the immune system]
Ilse Zündorf, Angelika M Vollmar, Theo Dingermann
Current Medicinal Chemistry. Cardiovascular and Hematological Agents
|
January 11, 2005
Vasoprotective actions of the atrial natriuretic peptide
Alexandra K Kiemer, Robert Fürst, Angelika M Vollmar
Immunology and Cell Biology
|
October 31, 2002
Inhibition of LPS-induced nitric oxide and TNF-alpha production by alpha-lipoic acid in rat Kupffer cells and in RAW 264.7 murine macrophages
Alexandra K Kiemer, Christian Müller, Angelika M Vollmar
Angiogenesis
|
August 14, 2010
Anti-angiogenic potential of small molecular inhibitors of cyclin dependent kinases in vitro
Stefan Zahler, Johanna Liebl, Robert Fürst, et al.
Page
of 16